All stock lists
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
2.07-0.14 (-6.33%)
Insider Score
––Not scored
ZNTL Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ZNTL Stock Insider Trading Activity
ZNTL stock’s insider trading shows 1 purchase for an estimated $15.17M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$15.17M bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Bruns Ingmar Other | Award | 9,727 | $2.18 | $21.20K | 29.2% | 43,059 | Sep 30, 2026 | — | Form 4 |
| WALTERS GROUP Other | Buy | 4,335,000 | $3.50 | $15.17M | 32.1% | 17,844,973 | Aug 14, 2026 | — | Form 4 |
| Skvarka Jan Director | Award | 57,100 | — | — | 27.6% | 264,254 | Jun 16, 2026 | — | Form 4 |
| Kariuki Enoch Director | Award | 57,100 | — | — | 41.6% | 194,465 | Jun 16, 2026 | — | Form 4 |
| Myers Scott Dunseth Director | Award | 57,100 | — | — | 16.9% | 395,895 | Jun 16, 2026 | — | Form 4 |
| Walker Luke Nathaniel Director | Award | 57,100 | — | — | 39.6% | 201,384 | Jun 16, 2026 | — | Form 4 |
| Johnson David Michael Director | Award | 57,100 | — | — | 22.8% | 307,521 | Jun 16, 2026 | — | Form 4 |
| Campbell Shannon Director | Award | 114,200 | — | — | New | 114,200 | May 26, 2026 | — | Form 4 |
| Vultaggio Vincent Other | Sell | 6,894 | $2.42 | $16.68K | 4.5% | 146,506 | Feb 10, 2026 | — | Form 4 |
| Bruns Ingmar Other | Sell | 335 | $2.39 | $800.65 | 1.0% | 33,332 | Feb 9, 2026 | — | Form 4 |
| EASTLAND JULIA MARIE CEO | Sell | 889 | $2.39 | $2.12K | 1.1% | 79,133 | Feb 9, 2026 | — | Form 4 |
| Vultaggio Vincent Other | Sell | 3,379 | $2.39 | $8.08K | 2.2% | 153,400 | Feb 9, 2026 | — | Form 4 |
| Bruns Ingmar Other | Sell | 2,962 | $2.43 | $7.20K | 8.1% | 33,667 | Feb 6, 2026 | — | Form 4 |
| Vultaggio Vincent Other | Sell | 29,951 | $2.43 | $72.78K | 16.0% | 156,779 | Feb 6, 2026 | — | Form 4 |
| EASTLAND JULIA MARIE CEO | Sell | 7,866 | $2.43 | $19.11K | 9.0% | 80,022 | Feb 6, 2026 | — | Form 4 |
| Vultaggio Vincent Other | Sell | 556 | $2.52 | $1.40K | 0.3% | 186,730 | Feb 3, 2026 | — | Form 4 |
| Vultaggio Vincent Other | Sell | 2,540 | $2.55 | $6.48K | 1.3% | 187,286 | Feb 2, 2026 | — | Form 4 |
| WALTERS WILLIAM THURMAN Other | Buy | 6,459,973 | $1.20 | $7.75M | 91.6% | 13,509,973 | Dec 31, 2025 | — | Form 4 |
| GOEL DAVID E. Other | Sell | 7,500,000 | $1.33 | $9.97M | 53.7% | 6,459,973 | Dec 15, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.